A clinical mutation in glucokinase causing maturity-onset diabetes in the young type 2 increases enzyme activity

Aranguiz, Oscar; Rivera, Rodrigo; Durruty, Pilar; Seelenfreund, Daniela; Baez, Mauricio

Abstract

Glucokinase (GCK) is the pancreatic ?-cell glucose sensor, and its kinetics are key to that purpose. A slow transition step, displayed as non-hyperbolic kinetics, and a low affinity for glucose characterize GCK. Mutations in GCK associated with maturity-onset diabetes of the young type 2 (MODY2) previously described reduce the functionality of the human pancreatic ?-cell, leading to diabetic clinical phenotypes. We present a kinetic characterization of the G448D mutation identified in a MODY2 patient, which is one of the first mutations to exhibit increased functionality. This mutant displays increased activity, high affinity for both Mg2+-ATP and glucose, hyperbolic kinetics and increased phosphorylation potential. Hyperbolic kinetics and assays in the presence of glycerol indicate that G448D lacks the slow transition step crucial for the pancreatic ?-cell glucose sensor function. © 2022 Federation of European Biochemical Societies.

Más información

Título según WOS: A clinical mutation in glucokinase causing maturity-onset diabetes in the young type 2 increases enzyme activity
Título según SCOPUS: A clinical mutation in glucokinase causing maturity-onset diabetes in the young type 2 increases enzyme activity
Título de la Revista: FEBS Letters
Volumen: 597
Número: 11
Editorial: John Wiley and Sons Inc.
Fecha de publicación: 2023
Página de inicio: 1469
Página final: 1478
Idioma: English
DOI:

10.1002/1873-3468.14561

Notas: ISI, SCOPUS